Matches in Wikidata for { <http://www.wikidata.org/entity/Q92744225> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92744225 description "article scientifique publié en 2020" @default.
- Q92744225 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92744225 description "scientific article published on 18 January 2020" @default.
- Q92744225 description "wetenschappelijk artikel" @default.
- Q92744225 description "наукова стаття, опублікована 18 січня 2020" @default.
- Q92744225 description "գիտական հոդված հրատարակված 2020 թվականի հունվարի 18-ին" @default.
- Q92744225 name "Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab" @default.
- Q92744225 name "Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab" @default.
- Q92744225 type Item @default.
- Q92744225 label "Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab" @default.
- Q92744225 label "Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab" @default.
- Q92744225 prefLabel "Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab" @default.
- Q92744225 prefLabel "Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab" @default.
- Q92744225 P1433 Q92744225-DABB602C-4EAB-4E5B-B260-4A9C420F868C @default.
- Q92744225 P1476 Q92744225-1059F781-3B92-48F7-84F6-FB51B80D84D6 @default.
- Q92744225 P2093 Q92744225-04218472-C1F7-424D-A8CF-D2BC2F8E8A4C @default.
- Q92744225 P2093 Q92744225-56281C02-8E98-45C6-8903-785C94CB016A @default.
- Q92744225 P2093 Q92744225-B2FFD141-E8FF-4832-81F7-5C529F682F49 @default.
- Q92744225 P2093 Q92744225-C96AD4EA-6735-456F-A42A-FE3CD95FE3DB @default.
- Q92744225 P2093 Q92744225-DFD0D2CD-F600-4122-9C7D-0D7BB7720128 @default.
- Q92744225 P2093 Q92744225-F662F01E-50E4-4EB5-B957-8372D63C2794 @default.
- Q92744225 P31 Q92744225-92C1E9A0-19AD-4C44-B621-E3377A422513 @default.
- Q92744225 P356 Q92744225-D632C20C-42AB-4AFE-A477-EDA6F6240A44 @default.
- Q92744225 P50 Q92744225-B1EDBC6A-6393-4A35-B4A1-9311975A2AD9 @default.
- Q92744225 P50 Q92744225-E7EEA198-EEF0-4A96-95C0-6C49325C7800 @default.
- Q92744225 P577 Q92744225-D4DBE570-8470-4D4D-9669-D1A94EF97ADF @default.
- Q92744225 P698 Q92744225-BE4170CE-231D-4956-8AE5-7610959CED83 @default.
- Q92744225 P921 Q92744225-474B63FF-B8AF-4016-97E9-37C67E6B84C1 @default.
- Q92744225 P921 Q92744225-BF75ADEC-52A5-42DB-AFEF-1DC6528A3353 @default.
- Q92744225 P356 BJD.18877 @default.
- Q92744225 P698 31954061 @default.
- Q92744225 P1433 Q4970191 @default.
- Q92744225 P1476 "Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab" @default.
- Q92744225 P2093 "I Otto" @default.
- Q92744225 P2093 "M Argyropoulou" @default.
- Q92744225 P2093 "N C Riedemann" @default.
- Q92744225 P2093 "O Zenker" @default.
- Q92744225 P2093 "R Guo" @default.
- Q92744225 P2093 "T Spyridopoulos" @default.
- Q92744225 P31 Q13442814 @default.
- Q92744225 P356 "10.1111/BJD.18877" @default.
- Q92744225 P50 Q37838104 @default.
- Q92744225 P50 Q92623916 @default.
- Q92744225 P577 "2020-01-18T00:00:00Z" @default.
- Q92744225 P698 "31954061" @default.
- Q92744225 P921 Q341999 @default.
- Q92744225 P921 Q348260 @default.